Table 2.
Studies | Location | Age (years) | Sample size | HBP (%) | OR 95% CI | Diabetes (%) | OR 95% CI | Dyslipidemia (%) | OR 95% CI | Cardiac diseases (%)/AF (%) | OR 95% CI |
---|---|---|---|---|---|---|---|---|---|---|---|
MBAGUI, R., 2009 [29] | Rabat | 39 | 93 YIS | 11,5 | – | 9,6 | – | 15,4 | – | – | – |
Abjaw, Z et al., 2009 [13] | Marrakech | 62,3 | 84 IS | 40,4 | – | 25 | – | 8,3 | – | 14,2 | – |
Rhissassi et al., 2010 [34] | Fes | 65,5 | 342 IS | – | – | – | – | – | – | – | – |
N A-Y AMESSAN., 2010 [15] | Rabat | 59,9 | 46 IS | 51 | – | 30 | – | 7 | – | 25/15 | – |
Chraa, M., 2010 [30] | Marrakech | – | 352 IS | 42,9 | – | 15,3 | – | 5,7 | – | 13,9 | – |
They TP et al., 2011 [40] | Casablanca | 49/46,2NS | 91 ISC/182Cl | 50,5/9,9**† | 9,3 4,9-17,6 | 17,6/8,8*† | 2,2 1,05-4,7 | – | – | – | – |
AZDAD, O., 2012 [33] | Fes | 66,3 | 1300 IS | 40,3 | – | 21,5 | – | 3,4 | – | 10,5 | – |
RACHDI, L., 2012 [27] | Meknes | 63 | 40 ISTr | 32 | – | 15 | – | 10 | – | 24/17 | – |
Bendriss, L et al., 2012 [17] | Marrakech | 60,8 | 110 IS | 65,4 | – | 41,8 | – | 10 | – | 19,9/9 | – |
Chtaou, N., 2012 [25] | Fes | 60,6 | 50 IS | 48 | – | 18 | – | 14 | – | −/22 | – |
Saraya, T., 2013 [35] | Rabat | 66,7 | 242IS | 56,2 | – | 38,4 | – | 13 | – | 18,9 | – |
Bourazza, A., 2013 [19] | Rabat | – | 1256IS | – | – | – | – | – | – | – | – |
They TP et al., 2013 [41] | Casablanca | 49/46,2NS | 91ISC/182Cl | 50,5/9,9**Ω | – | 17,6/8,8* Ω | – | – | – | – | – |
Ibouajbane, M., 2014 [31] | Meknes | 36 | 40 YIS | 12,5 | – | 7,5 | – | 0 | – | – | – |
Balar, K et al., 2014 [36] | Casablanca | 57 | 165 | 50,5 | – | 21,3 | – | 11 | – | – | – |
Chraa, M et al., 2014 [22] | Marrakech | 28,3 | 128 YIS | 49,2 | – | 13,2 | – | 7,8 | – | – | – |
Diakite, B et al., 2014 [39] | Casablanca | 56,5 | 165 | – | – | – | – | – | – | – | – |
Allaoui, A et al., 2018 [43] | Casablanca | 36 | 25YIS | 8 | – | 8 | – | – | – | – | – |
RACHDI., L et al., 2015 [28] | Fes | 66 | 439 IS | 43 | – | 29 | – | 0 | – | −/7 | – |
Belkouch et al., 2015 [16] | Rabat | 63 | 13 IS | – | – | – | – | – | – | – | – |
Chraa, M., 2015 [21] | Marrakech | 61 | 665 IS | 42,9 | – | 15,3 | – | 5,7 | – | 44,3 | – |
Diakite, B et al., 2015 [37] | Casablanca | 57 | 170 IS | 50,6 | – | 22,9 | – | 9,4 | – | – | – |
Benkirane, N et al.,2015 [18] | C and R‡ | 59,5 | 157 IS | 59,9 | – | 31,2 | – | 61,8 | – | – | – |
Yonmadji, N., 2016 [32] | Fes | 64,9 | 1184 IS | 39,4 | – | 30 | – | 5,8 | – | 9,6/2,5 | – |
Daouda et al., 2018 [24] | Fes | 67,3 | 46 IStr | – | – | – | – | – | – | – | – |
Diakite, B et al., 2016 [38] | Casablanca | 57,1 | 175 IS | 50,3 | – | 20,6 | – | 9,4 | – | – | – |
Chraa M et al., 2017 [20] | Marrakech | 61 | 442 IS | 42,9 | – | 15,3 | – | – | – | 44,3/13,9 | – |
Hadi, A et al., 2018 [26] | Marrakech | 66,3 | 230 IS | 61 | – | 41 | – | 9 | – | 28,9/9 | – |
Chtaou, N et al., 2016 [23] | Fes | 63 | 52 IS | 31 | – | 12 | – | 8 | – | 27/17 | – |
AF Atrial fibrillation, IS Ischemic Stroke, ISC Ischemic stroke cases, Cl Controls, NS Not significant, YIS Young Ischemic Stroke, ISTr Ischemic stroke trombolysed, Ob Obesity, M Migraine, HBP High Blood Pressure, ‡ Casablanca and Rabat;* P-value< 0,05; **P-value< 0,001; †: P-values obtained using Mantel–Haenszel chi-square exact test; Ω P value obtained using Fisher’s exact test, OR Odds ratio, CI confidence interval